Go Pro
→ CODE RED: AI Meltdown Imminent? (From Paradigm Press) (Ad)tc pixel Free ALGN Stock Alerts

Align Technology (ALGN) Competitors

Align Technology logo
$172.36 -0.53 (-0.30%)
As of 02:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

Should you buy Align Technology stock or one of its competitors? MarketBeat compares Align Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Align Technology include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), and Quanterix (QTRX).

How does Align Technology compare to DexCom?

Align Technology (NASDAQ:ALGN) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Align Technology has a beta of 1.65, indicating that its stock price is 65% more volatile than the broader market. Comparatively, DexCom has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market.

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.03B3.06$410.35M$5.7529.98
DexCom$4.66B7.04$836.30M$2.5334.37

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, DexCom had 27 more articles in the media than Align Technology. MarketBeat recorded 58 mentions for DexCom and 31 mentions for Align Technology. DexCom's average media sentiment score of 0.88 beat Align Technology's score of 0.87 indicating that DexCom is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
15 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
DexCom
24 Very Positive mention(s)
5 Positive mention(s)
20 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Align Technology presently has a consensus target price of $206.36, suggesting a potential upside of 19.72%. DexCom has a consensus target price of $88.71, suggesting a potential upside of 2.03%. Given Align Technology's higher probable upside, equities analysts plainly believe Align Technology is more favorable than DexCom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67
DexCom
1 Sell rating(s)
3 Hold rating(s)
21 Buy rating(s)
2 Strong Buy rating(s)
2.89

DexCom has a net margin of 20.12% compared to Align Technology's net margin of 9.99%. DexCom's return on equity of 35.94% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology9.99% 15.86% 10.32%
DexCom 20.12%35.94%14.75%

Summary

DexCom beats Align Technology on 13 of the 17 factors compared between the two stocks.

How does Align Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

HealthEquity has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, meaning that its stock price is 65% more volatile than the broader market.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 0.8% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Align Technology has higher revenue and earnings than HealthEquity. Align Technology is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.31B6.64$215.20M$2.6739.07
Align Technology$4.03B3.06$410.35M$5.7529.98

In the previous week, Align Technology had 24 more articles in the media than HealthEquity. MarketBeat recorded 31 mentions for Align Technology and 7 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.53 beat Align Technology's score of 0.87 indicating that HealthEquity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Align Technology
15 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

HealthEquity has a net margin of 17.25% compared to Align Technology's net margin of 9.99%. Align Technology's return on equity of 15.86% beat HealthEquity's return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.25% 14.75% 9.22%
Align Technology 9.99%15.86%10.32%

HealthEquity presently has a consensus target price of $110.93, indicating a potential upside of 6.33%. Align Technology has a consensus target price of $206.36, indicating a potential upside of 19.72%. Given Align Technology's higher possible upside, analysts clearly believe Align Technology is more favorable than HealthEquity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.77
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Align Technology beats HealthEquity on 9 of the 17 factors compared between the two stocks.

How does Align Technology compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Align Technology has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Henry Schein$13.18B0.76$398M$3.3126.66
Align Technology$4.03B3.06$410.35M$5.7529.98

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.9% of Henry Schein shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Align Technology has a net margin of 9.99% compared to Henry Schein's net margin of 2.95%. Align Technology's return on equity of 15.86% beat Henry Schein's return on equity.

Company Net Margins Return on Equity Return on Assets
Henry Schein2.95% 15.44% 5.53%
Align Technology 9.99%15.86%10.32%

Henry Schein has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, meaning that its stock price is 65% more volatile than the broader market.

In the previous week, Align Technology had 7 more articles in the media than Henry Schein. MarketBeat recorded 31 mentions for Align Technology and 24 mentions for Henry Schein. Align Technology's average media sentiment score of 0.87 beat Henry Schein's score of 0.52 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Henry Schein
8 Very Positive mention(s)
1 Positive mention(s)
11 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
15 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Henry Schein presently has a consensus target price of $89.36, indicating a potential upside of 1.26%. Align Technology has a consensus target price of $206.36, indicating a potential upside of 19.72%. Given Align Technology's stronger consensus rating and higher possible upside, analysts plainly believe Align Technology is more favorable than Henry Schein.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
1 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.47
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Align Technology beats Henry Schein on 13 of the 16 factors compared between the two stocks.

How does Align Technology compare to Medpace?

Align Technology (NASDAQ:ALGN) and Medpace (NASDAQ:MEDP) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 20.5% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Align Technology currently has a consensus price target of $206.36, indicating a potential upside of 19.72%. Medpace has a consensus price target of $584.18, indicating a potential upside of 1.59%. Given Align Technology's stronger consensus rating and higher possible upside, equities analysts plainly believe Align Technology is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67
Medpace
0 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.15

Align Technology has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market. Comparatively, Medpace has a beta of 1.15, meaning that its share price is 15% more volatile than the broader market.

In the previous week, Align Technology had 5 more articles in the media than Medpace. MarketBeat recorded 31 mentions for Align Technology and 26 mentions for Medpace. Medpace's average media sentiment score of 1.25 beat Align Technology's score of 0.87 indicating that Medpace is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
15 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Medpace
22 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Medpace has lower revenue, but higher earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.03B3.06$410.35M$5.7529.98
Medpace$2.53B6.34$451.12M$17.0633.71

Medpace has a net margin of 17.67% compared to Align Technology's net margin of 9.99%. Medpace's return on equity of 110.15% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology9.99% 15.86% 10.32%
Medpace 17.67%110.15%24.84%

Summary

Medpace beats Align Technology on 9 of the 17 factors compared between the two stocks.

How does Align Technology compare to Quanterix?

Quanterix (NASDAQ:QTRX) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

Quanterix presently has a consensus target price of $4.00, indicating a potential upside of 8.81%. Align Technology has a consensus target price of $206.36, indicating a potential upside of 19.72%. Given Align Technology's stronger consensus rating and higher possible upside, analysts clearly believe Align Technology is more favorable than Quanterix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

86.5% of Quanterix shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.5% of Quanterix shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Quanterix has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market.

Align Technology has a net margin of 9.99% compared to Quanterix's net margin of -71.86%. Align Technology's return on equity of 15.86% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Quanterix-71.86% -23.92% -17.66%
Align Technology 9.99%15.86%10.32%

In the previous week, Align Technology had 30 more articles in the media than Quanterix. MarketBeat recorded 31 mentions for Align Technology and 1 mentions for Quanterix. Align Technology's average media sentiment score of 0.87 beat Quanterix's score of 0.00 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quanterix
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Align Technology
15 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quanterix$138.90M1.25-$107.15M-$2.36N/A
Align Technology$4.03B3.06$410.35M$5.7529.98

Summary

Align Technology beats Quanterix on 16 of the 17 factors compared between the two stocks.

Get Align Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALGN vs. The Competition

Export
MetricAlign TechnologyHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$12.35B$5.70B$6.80B$13.01B
Dividend YieldN/A1.78%2.60%10.03%
P/E Ratio29.9923.54279.9825.51
Price / Sales3.0659.23649.35116.02
Price / Cash14.2532.5328.6434.82
Price / Book3.056.5011.156.35
Net Income$410.35M$151.72M$3.48B$347.60M
7 Day Performance-1.84%6.11%2.51%3.14%
1 Month Performance-6.59%0.89%-2.78%-2.08%
1 Year Performance25.11%9.82%64.32%21.27%

Align Technology Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALGN
Align Technology
3.6791 of 5 stars		$172.36
-0.3%		$206.36
+19.7%		+26.6%$12.35B$4.03B29.9920,290
DXCM
DexCom
3.7483 of 5 stars		$73.37
+2.6%		$85.36
+16.3%		+10.1%$27.61B$4.66B31.3511,000
HQY
HealthEquity
3.9231 of 5 stars		$99.05
+4.7%		$110.93
+12.0%		+14.6%$7.91B$1.31B37.102,814
HSIC
Henry Schein
3.2238 of 5 stars		$84.61
-1.0%		$88.62
+4.7%		+27.3%$9.74B$13.18B25.5625,000
MEDP
Medpace
3.0203 of 5 stars		$589.37
-2.0%		$560.92
-4.8%		+35.5%$16.79B$2.53B34.556,200

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ALGN) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Nvidia's CEO says this small device is critical for AI growth
A tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it esse...
Brownstone Research | Sponsoredtc pixel
1 Stock to Own by July 31st
A scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-k...
Chaikin Analytics | Sponsoredtc pixel
He bet half his $9 billion on ONE stock
One of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...
Banyan Hill Publishing | Sponsoredtc pixel
Central banks bought 710 tonnes - this fund pays monthly
Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...
Investors Alley | Sponsoredtc pixel